Guanine-Decorated Graphene Nanostructures for Sensitive Monitoring of Neuron-Specific Enolase Based on an Enzyme-Free Electrocatalytic Reaction
A new and enzyme-free electrochemical immunoassay protocol was developed for the sensitive electronic monitoring of neuron-specific enolase (NSE) on a monoclonal mouse anti-human NSE antibody (mAb)-modified glassy carbon electrode, using guanine-decorated graphene nanostructures (GGN) as nanotags. T...
Saved in:
| Published in | Analytical Sciences Vol. 29; no. 12; pp. 1195 - 1201 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Singapore
The Japan Society for Analytical Chemistry
2013
Springer Nature Singapore Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0910-6340 1348-2246 1348-2246 |
| DOI | 10.2116/analsci.29.1195 |
Cover
| Summary: | A new and enzyme-free electrochemical immunoassay protocol was developed for the sensitive electronic monitoring of neuron-specific enolase (NSE) on a monoclonal mouse anti-human NSE antibody (mAb)-modified glassy carbon electrode, using guanine-decorated graphene nanostructures (GGN) as nanotags. To construct such an enzyme-free immunoassay format, guanine and polyclonal rabbit anti-human NSE antibody (pAb) were co-immobilized on the graphene nanostructures through the carbodiimide coupling. Based on a sandwich-type immunoassay mode, the assay was carried out in 0.1 M pH 7.4 PBS containing 5 μM Ru(bpy)32+ through the catalytic oxidation of Ru(bpy)32+ toward the guanine on the GGN. The presence of graphene nanostructures increased the immobilized amount of guanine, thus amplifying a detectable electronic signal. The covalent conjugation of guanine and pAb on the GGN resulted in a good repeatability and intermediate reproducibility down to 9.5%. Under optimal conditions, the dynamic concentration range of the developed immunoassay spanned from 0.005 to 80 ng mL−1 NSE with a detection limit of 1.0 pg mL−1 at the 3Sblank level. In addition, the methodology was evaluated by assaying the spiking serum samples, and the relative standard deviation (RSD) between the electrochemical immunoassay and a commercialized enzyme-linked immunosorbent assay (ELISA) were 2.8 – 7.0%. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ISSN: | 0910-6340 1348-2246 1348-2246 |
| DOI: | 10.2116/analsci.29.1195 |